{"name":"Excellergy Inc.","slug":"excellergy-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQak5aQWtZcElPa0hZN29GUV8yTGdYZGg0TmtOZmdFMDNTTm50cklhaUdIYVZYeDM3TEdoSTI3MnRsaGdsNWNTS0kxNGs4OFFQRXhXVmFaVXJvb2hHMjE5YldDVVBUODZsMlR3UzVfYnQzYW54cUNzamh4aWJNdmp1MEtvNFJNaWVYZHFpcmE0ejFQV2VwZ1Bydkt0YVV2Sy1xZ3BKaXJLVEMtZUFzMHZBTlZKeUU?oc=5","date":"2026-04-06","type":"earnings","source":"TradingView","summary":"Pharma, Biotech Giants Ramp Up M&A in Q1 to Boost Pipelines - TradingView","headline":"Pharma, Biotech Giants Ramp Up M&A in Q1 to Boost Pipelines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPWDVEZ0VCRW93QVE2YVJvWmVXR0JOdXNwaWxBVnFCUW1IRkg1Q3l3Nm9ZNVVocHJJUi1GUjF6MHBoZWJyZG5jTFJRQWxYZVJHMllpcjZUT3JCc3ZqSlhyQ1p0aGphUU9sZi14YmNDRzMwWnc2TE52NmlPMmFhMzN2R3dIVjQxeTl5WHdB0gGQAUFVX3lxTE9vdDRvQ3F5dFdaem0yUkFGTVFRdEI0ZE5EeWxtUzRiTk9GQTVxcllvenpMMEdQYm1ERWxiRUJORmtFUTU1WFY5Q2ZlaGJ3LTJzUnprZGVfZUJWUzJIT0JaV01iZ2VNSlhLTko5TWp1RFFEbFQ2dThPTTFvVFpXMGwwWWgtVENvWHFwd3ZVUTdLcA?oc=5","date":"2026-03-27","type":"deal","source":"CNBC","summary":"Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week - CNBC","headline":"Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNck1yLUJyMnBuRHJkSmY4Z1h6dUNwS0FFQUxmOGVDWS14QXFHNnNIMzJuTndUWWFzODJSalZYdEd1WjktN1ZKdmhNS1pvRElOajlXalBNaFB6OC15Z1FqNml2ZUo3LWtZR244XzRsRlFmVHExM3NydzU5LXkwUmFXVUhfLWlqeXlQWGV1TXVYRlJfdG1lZktsdFVpTko1Zw?oc=5","date":"2026-03-27","type":"deal","source":"wsj.com","summary":"Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion - wsj.com","headline":"Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOVEhsNlJYR00wUkNiVmRLaUdFWjBHU0t6cnFBeVNhTF9iQWI1ZEJoVGt0b2ZCSlN5TnFCdEUtYXlnSXVNd3lOTmVrZElYczVSTlB6Vll0TTEwbFIzTENIeXQ3UU5FWUVuQV9uTnVlTkxua1hpREhGVUFPdXJuVXpXRVZYbERJcjBjaDhta3hNYS16V05CRHdrZkhmYm9VYkxQeDlQT0VWaHpVUVpadEVLbHYzNHljZU9mVXBZZ1hxYUpHcy0tNV9PdklR?oc=5","date":"2026-03-27","type":"pipeline","source":"Reuters","summary":"Novartis to pay up to $2 billion for US biotech firm Excellergy - Reuters","headline":"Novartis to pay up to $2 billion for US biotech firm Excellergy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPSU95b0pEby1yODVCbnlsTTRxbHlEZ2w2STh1R0JBcWpnZ0ZWRDVWYUx0UVJveHBzejlFUmE4V3pvV2syYThNTGNyc0pvS3Z3UlhqMVo4ZHBMcTZjajBGN05qa3EyaE1Dd1NUOGFuQ1ZfenZCOUxsR3AyZlJvaVF1ZmFMMDE3MXhYUDd4SE95VHFBUQ?oc=5","date":"2026-03-27","type":"deal","source":"BioPharma Dive","summary":"Novartis targets Xolair successor in buyout of startup Excellergy - BioPharma Dive","headline":"Novartis targets Xolair successor in buyout of startup Excellergy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPR19wWE5kMFEtbFpDSkJWVGNhb1ZuN01uakJXbVJzNnZDSFl0RUZYOEt1dE00azYyak9QMUl6N0lqU0FvRW1TSmdjTElTdXJzT0UxeE1rT2ZVU2hCN3o4OTRhTDV0dWR4MDFYZ1pwZXkydEVjTmxVY1dTYWp0N0ZvS0ZqbFR1QzNVUG1iVnc1VQ?oc=5","date":"2026-03-27","type":"deal","source":"BioSpace","summary":"Novartis Keeps Deals Coming With $2B Excellergy Takeover - BioSpace","headline":"Novartis Keeps Deals Coming With $2B Excellergy Takeover","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOMVl0U3dST3hxRUhQZkY4a3BuNE1FcUhQdUJUakpaQmhTS1lLcFFIb05Td2lpeXctbUVxZXRUMHpDTklJaXVJUkw3dHg1VHBSMHdBU09saWhKaG5ZWUM0NWNpcmlaU19MQXNaNDl3M1RjMXkzRHZxbno0UnJ2Ti1fZDdWZzhZQU5kUmVN?oc=5","date":"2026-03-27","type":"deal","source":"Contract Pharma","summary":"Novartis Agrees to Acquire Excellergy - Contract Pharma","headline":"Novartis Agrees to Acquire Excellergy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNZmFDS1FoSk5iSklqdDRWQ3RxeU40NWRtWEpucWRZRlJHUzJrb3BCQ3BZVVhzdU4xWlJIOEM2ckdMVEhYcEdGZ1BYQVM0dzJSeDJtcVlxeDM3XzlzVXZJdi1ENV9WZ0tXZzNOLUZVeWxJTlo0UWc3ODgtRWhZZV9GM1dKdzk4NHd3YUE?oc=5","date":"2026-03-27","type":"deal","source":"Pharmaceutical Technology","summary":"Novartis to acquire Excellergy for $2bn upfront - Pharmaceutical Technology","headline":"Novartis to acquire Excellergy for $2bn upfront","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQUjV3bHFNQmZ4X2FIMUpqVkhEUHdBY01VRGQtV3RBd2dzZDg2VmlFNDhkbjFyQWZ2aUJqekppM1dQY2tpSWdVZ1d5Nll0NnRMcHFWQXc1YlBoNDhreUVyZWZ0eWFJSWpWcWVBMFU5Y3VfVDljbl91RnAwV3pTSVhWcXUxLU1FNkUxWUZsVGpGc3E1dks5NTN4YVd3cTYtd3g2NjR5OA?oc=5","date":"2026-03-27","type":"deal","source":"Fierce Biotech","summary":"Novartis pens $2B deal for allergy biotech with potential Xolair successor - Fierce Biotech","headline":"Novartis pens $2B deal for allergy biotech with potential Xolair successor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxOSG9JaU5oaTJZdExhemhqOU1xV0REenVaN0g5S3hVTFpnT2lHY185OVdhaTBiV0d1NFdIZHlDNGJmOWF2RkNwUFJrdFRjU2ltZHlhN19wUFhOeTBwdG1yQnlBUEhRNmsySnI5TWVaNFVOcTBtYnJNS2s0bHFVVjJCRFN1akIzSFNfYWRNcmNIQVBQVHJJaVZ6ZGdFX3NIWDI4QXdyQUpNUXZ6OEwxbU1hWTdJZmRyekhCcEV1QlQxMk5ZRm91aEJqR1lXcWdFdkxKbjV1QW9IU1FyblRjRVRTMTZ0Rm9UTXQ4ZEFkdUlkanc1cThsTjJnTHdLWFZXdW9DREtud3pKdUpxaGw1TjZzX2FOSQ?oc=5","date":"2026-03-27","type":"deal","source":"GlobeNewswire","summary":"Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation - GlobeNewswire","headline":"Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNT1g4ei1aSEl4TlY0QkkyR2p3ZGtBQzBLMms4TVc1RVhHWmhNeEdRNlJyM2VfTU9oNElYemJiYkdjVHhrMlBldTY0RVk0bDl4b1V3WVdqYXRUU3hVRnMzODJMbmtINWc1TE5tOTFrUjJsRnpPNDdBY0tmYWFEckFhVkhPUHZhekFWSXdwY2NEN3p0QkpNbVdfcS1XS0w5QkVxSFVtbTE2SQ?oc=5","date":"2026-03-27","type":"deal","source":"The Pharma Letter","summary":"Novartis to expand allergy portfolio with buy of Excellergy - The Pharma Letter","headline":"Novartis to expand allergy portfolio with buy of Excellergy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPVGlUa01wcDQ3bDdoZWxnZXcwSmV5RWo1LUFHOXowbDdBSUk5Mk9xRnJZcVBBZ0wxWDRGUHI1WkdwUnhKbEFNYmNBMUFmREp0cW9feE4tdUt5WW05SDhmVk1JOXNwakJTWUtRel9TMlVuUjhNVFFhSGRtNW5zNkJuWDZROA?oc=5","date":"2026-03-27","type":"pipeline","source":"pharmaphorum","summary":"Novartis snaps up food allergy firm Excellergy for $2bn - pharmaphorum","headline":"Novartis snaps up food allergy firm Excellergy for $2bn","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}